EFTA01582317

Statement of Account **• ALL AMOUNTS IN US DOLLAR TYPE LONG OR DESCRIPTION SHORT IS) INV REP ACCOUNT TAXPAYER ID. STATEMENT PERIOD PAGE 20.10 UNDISCLOSED 12/01/05 TO 12/31/05 19 OF 21 PORTFOLIO PRICE MARKET VALUE ESTIMATED ANNUAL INCOME CURRENT YIELD % 03 109,990 (S) PPL CORP 29.40000 3,233,706.00- 109,990.00- 3.401 03 62,160 (S) RPM INCORPORATED 17.37000 1,079,719.20- 39,782.40- 3.685 03 21,140 (S) SUPERVALU INC 32.48000 686,627.20- 13,741.00- 2.001 03 53,590 (S) TJX COMPANIES INC NEW 23.23000 1,244,895.70- 12,861.60- 1.033 *CSFB RATING :OUTPERFORM INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard S POOr'S 03 8,665 (S) UNISOURCE ENERGY CORP HLDG CO 31.20000 270,348.00- 6,585.40- 2.436 03 5,322 (S) VALASSIS COMMUNICATION INC 29.07000 154,710.54- *CSFB RATING :NEUTRAL INDEPENDENT RATING:Hold PROVIDER:Rochdale Securities 03 12,533 (S) VORNADO REALTY TR 83.47000 1,046,129.51- 38,601.64- 3.690 *CSFB RATING :NOT AVAILABLE INDEPENDENT RATING:4 STAR - Accumulate PROVIDER:Standard & Poor's 03 13,240 (S) WYETH 46.07000 609,966.80- 13,240.00- 2.171 *CSFB RATING :NEUTRAL INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard & Poor's 01 3,366,000 ALLERGAN INC SR NT CV ZERO 22 122.25000 4,114,935.00 11/06/2022 01 2,000,000 AMERICAN FINL GROUP INC OHIO SR 44.00000 880,000.00 29,720.00 3.377 NT CV1. 01.4861 06/02/2033 01 2,000,000 AMGEN INC NT ZER CV 32 78.00000 1,560,000.00 03/01/2032 01 1,000,000 AMYLIN PHARMACEUTICALS INC SR 127.12500 1,271,250.00 25,000.00 1.967 NT CV 2 02.5000 04/15/2011 01 17,000 BARNES GROUP INC CVT 144A 99.00000 16,830.00 637.50 3.788 03.7500 08/01/2025 )1 3,000,000 CBRL GROUP INC LYON ZERO 32 45.00000 1,350,000.00 04/03/2032 )1 700,000 CMS ENERGY CORP SR NT-B CV 23 143.87500 1,007,125.00 23,625.00 CREDIT FIRST I SUISSE BOSTON 03.3750 07/15/2023 CREDIT SUISSE FIRST BOSTON LLC TEL ELEVEN MADISON AVENUE FAX NEW YORK, NY 10010-3629 Confidential Treatment Requested by JPMorgan Chase JPM-SDNY-00061840 EFTA01582317